Drug Profile
Food allergy DNA vaccine
Latest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Allergens; Food allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Food hypersensitivity
Most Recent Events
- 26 Apr 1999 New profile
- 26 Apr 1999 Preclinical development for Food allergy in USA (PO)